NanoViricides, Inc. (NNVC)
USD 1.5
(0.67%)
USD 1.5
(0.67%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.31 Million | -5.67 Million | -5.89 Million | -8.21 Million | -6.66 Million | -6.8 Million |
| Net Income | -8.29 Million | -8.58 Million | -8.1 Million | -8.82 Million | -13.44 Million | -8.42 Million |
| Depreciation & Amortization | 759.01 Thousand | 747.52 Thousand | 723.32 Thousand | 704.53 Thousand | 699.72 Thousand | 695.91 Thousand |
| Deferred income taxes | - | -99.09 Thousand | - | 8129.00 | 5.23 Million | -191.66 Thousand |
| Stock-based compensation | 222.18 Thousand | 214.17 Thousand | 338.41 Thousand | 405.59 Thousand | 559.39 Thousand | 532.32 Thousand |
| Change in working capital | 996.87 Thousand | 1.79 Million | 214.56 Thousand | -540.11 Thousand | 119.66 Thousand | 567.7 Thousand |
| Other non-cash items | 705.81 Thousand | 257.09 Thousand | 939.3 Thousand | 30.2 Thousand | 163.95 Thousand | 17.39 Thousand |
| Investing Cash Flow | -156.56 Thousand | -151.71 Thousand | -324.34 Thousand | -238.76 Thousand | -8638.00 | -73.79 Thousand |
| Investments in PPE | -156.56 Thousand | -151.71 Thousand | -324.34 Thousand | -238.76 Thousand | -8638.00 | -73.79 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 3.12 Million | -94.78 Thousand | -234.71 Thousand | 15.26 Million | 17.82 Million | 2.35 Million |
| Debt repayment | - | -94.78 Thousand | -234.71 Thousand | -1.3 Million | -92.33 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.12 Million | - | - | 16.56 Million | 16.67 Million | 2.35 Million |
| Other Financing Activities | 3.12 Million | -94.79 | -234.72 | 15.26 Thousand | 1.24 Million | 2350.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 705.81 Thousand | 118.13 Thousand | 40.8 Thousand | -710.75 Thousand | 110.63 Thousand | 802.86 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 291.05 Thousand | 1.68 Million | 173.76 Thousand | 170.64 Thousand | 9033.00 | -235.16 Thousand |
| Cash at beginning of period | 8.14 Million | 14.06 Million | 20.51 Million | 13.7 Million | 2.55 Million | 7.08 Million |
| Cash at end of period | 4.79 Million | 8.14 Million | 14.06 Million | 20.51 Million | 13.7 Million | 2.55 Million |
| Capital Expenditure | -156.56 Thousand | -151.71 Thousand | -324.34 Thousand | -238.76 Thousand | -8638.00 | -73.79 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -3.35 Million | -5.91 Million | -6.45 Million | 6.8 Million | 11.15 Million | -4.52 Million |
| Free Cash Flow | -6.47 Million | -5.82 Million | -6.21 Million | -8.45 Million | -6.67 Million | -6.87 Million |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.35 Million | -1.85 Million | -2.11 Million | -1.96 Million | -8.58 Million | -3.56 Million |
| Depreciation & Amortization | 190.6 Thousand | 189.95 Thousand | 189.33 Thousand | 189.12 Thousand | 747.52 Thousand | 188.88 Thousand |
| Deferred income taxes | - | - | -264.25 Thousand | -72.14 Thousand | -99.09 Thousand | - |
| Stock-based compensation | 48.33 Thousand | 54.77 Thousand | 47.6 Thousand | 71.46 Thousand | 214.17 Thousand | 50.45 Thousand |
| Change in working capital | 635.59 Thousand | -333.89 Thousand | 158.87 Thousand | 536.3 Thousand | 1.79 Million | 1.67 Million |
| Other non-cash items | 541.77 | 650.98 Thousand | 264.4 Thousand | 72.3 Thousand | 257.09 Thousand | 157.11 Thousand |
| Investing Cash Flow | -98.16 Thousand | -44.63 Thousand | -5474.00 | -8291.00 | -151.71 Thousand | -2566.00 |
| Investments in PPE | -98.16 Thousand | -44.63 Thousand | -5474.00 | -8291.00 | -151.71 Thousand | -2566.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 3.12 Million | - | - | - | -94.78 Thousand | - |
| Debt repayment | - | - | - | - | -94.78 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.12 Million | - | - | - | - | - |
| Other Financing Activities | 3120.04 | - | - | - | -94.79 | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 541.76 Thousand | -216.16 Thousand | 162.01 Thousand | 218.19 Thousand | 118.13 Thousand | 83.91 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 93.83 | -117.73 Thousand | -3138.00 | 318.1 Thousand | 1.68 Million | 1.59 Million |
| Cash at beginning of period | 3.25 Million | 5.24 Million | 6.96 Million | 8.14 Million | 14.06 Million | 9.65 Million |
| Cash at end of period | 4.79 Million | 3.25 Million | 5.24 Million | 6.96 Million | 8.14 Million | 8.14 Million |
| Capital Expenditure | -98.16 Thousand | -44.63 Thousand | -5474.00 | -8291.00 | -151.71 Thousand | -2566.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.54 Million | -1.98 Million | -1.72 Million | -1.17 Million | -5.91 Million | -1.5 Million |
| Free Cash Flow | -1.57 Million | -1.98 Million | -1.72 Million | -1.17 Million | -5.82 Million | -1.5 Million |
GEVI
XPG
002117
NVNO
GRN
301020